GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (CHIX:BANBz) » Definitions » EV-to-EBITDA

Bachem Holding AG (CHIX:BANBZ) EV-to-EBITDA : 38.70 (As of May. 17, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bachem Holding AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bachem Holding AG's enterprise value is CHF6,558.0 Mil. Bachem Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF169.4 Mil. Therefore, Bachem Holding AG's EV-to-EBITDA for today is 38.70.

The historical rank and industry rank for Bachem Holding AG's EV-to-EBITDA or its related term are showing as below:

CHIX:BANBz' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.99   Med: 24.96   Max: 99.84
Current: 38.71

During the past 13 years, the highest EV-to-EBITDA of Bachem Holding AG was 99.84. The lowest was 9.99. And the median was 24.96.

CHIX:BANBz's EV-to-EBITDA is ranked worse than
82.16% of 1289 companies
in the Chemicals industry
Industry Median: 14.09 vs CHIX:BANBz: 38.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Bachem Holding AG's stock price is CHF90.525. Bachem Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.000. Therefore, Bachem Holding AG's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bachem Holding AG EV-to-EBITDA Historical Data

The historical data trend for Bachem Holding AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bachem Holding AG EV-to-EBITDA Chart

Bachem Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.03 47.01 63.29 38.63 27.00

Bachem Holding AG Quarterly Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.29 - 38.63 - 27.00

Competitive Comparison of Bachem Holding AG's EV-to-EBITDA

For the Chemicals subindustry, Bachem Holding AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bachem Holding AG's EV-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bachem Holding AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's EV-to-EBITDA falls into.



Bachem Holding AG EV-to-EBITDA Calculation

Bachem Holding AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6558.031/169.443
=38.70

Bachem Holding AG's current Enterprise Value is CHF6,558.0 Mil.
Bachem Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF169.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bachem Holding AG  (CHIX:BANBz) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bachem Holding AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=90.525/0.000
=N/A

Bachem Holding AG's share price for today is CHF90.525.
Bachem Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bachem Holding AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bachem Holding AG (CHIX:BANBZ) Business Description

Traded in Other Exchanges
Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Bachem Holding AG (CHIX:BANBZ) Headlines

No Headlines